A New Jersey federal judge has granted final approval to the $1.06 billion settlement between Merck & Co. Inc. and the drug company’s investors to resolve multidistrict litigation (MDL)... Read more
As most of those who receive the Report and are familiar with our firm know, our Mass Torts Section was closely involved in the Vioxx litigation against Merck. Led by Andy Birchfield, who no... Read more
Merck & Co. Inc. has agreed to settle a class action lawsuit filed on behalf of Missouri consumers over the prescription pain reliever Vioxx. The settlement is expected to cost the drug... Read more
New York will receive $61 million from a national settlement with Merck & Co. This will resolve an investigation into the marketing of the painkiller Vioxx. A federal court has accepted... Read more
Pharmaceutical giant Merck has agreed to pay up to $36.8 million to settle all lawsuits brought against the company in Canada over its former best-selling painkiller Vioxx. As we all know, M... Read more
Drug maker Merck will pay $950 million to resolve investigations into its marketing of the painkiller Vioxx. Merck will pay $321.6 million in criminal fines and $628.4 million as a civil set... Read more
Frank Woodson joined our firm in 2001. He was a former partner in the general litigation firm of Turner, Onderdonk, Kimbrough & Howell in Mobile, Ala., where his practice focused on lit... Read more
In 2000, our firm decided to get involved in Mass Torts Litigation in a big way. When we handled cases in the massive Fen Phen litigation, the firm realized that a change was needed. Once th... Read more
The U.S. Supreme Court says investors who lost millions when Merck & Co. pulled its blockbuster drug Vioxx off the market can proceed with their lawsuit against the pharmaceutical giant.... Read more
From the beginning, negotiating Plaintiffs’ counsel have been resolute in their conviction that the Vioxx Settlement Program should be fair and efficient. It is encouraging, therefore, to re... Read more
If you would like to subscribe to the Jere Beasley Report digital edition, simply visit our Subscriptions page and provide the necessary information or call us at 800-898-2034.
Attorney Advertising - Prior results do not guarantee a similar outcome.